Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : SNAP Biosciences
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Monarch and SNAP Biosciences Sign Licensing Deal for SNAP-CAR NK Cell Therapy in Oncology
Details : The agreement to enable the development and commercialization of SNAP Biosciences’ proprietary Snap-Car NK cell therapy platform in oncology using Monarch’s small molecule adaptor technology.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
May 28, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : SNAP Biosciences
Deal Size : Undisclosed
Deal Type : Licensing Agreement